muscular dystrophy therapy (OSI/MRC/CHSL)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemuscular dystrophy therapy (OSI/MRC/CHSL)
Drug Alias NameDMD therapy (OSI Pharmaceuticals/MRC/CHSL)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsi Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCold Spring Harbor LaboratoryOsi Pharmaceuticals IncMedical Research Council
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies

Other Information

ATC CodeN/A
Related LinksN/A